Ocena pierwszego polskiego stentu "Neptun" w leczeniu zmian miażdżycowych tętnic biodrowych by Juszkat, Robert et al.
87
o r i g i n a l  a r T i C l E
Evaluation of the first polish stent „Neptun” in the 
treatment of arteriosclerosis of the iliac arteries
Ocena pierwszego polskiego stentu „Neptun” w leczeniu zmian 
miażdżycowych tętnic biodrowych
Robert Juszkat1, Zbigniew Krasiński2, Marek Winckiewicz2
1 Department of Radiology, Karol Marcinkowski Medical University in Poznan, Poland  
2 Department of General and Vascular Surgery, Karol Marcinkowski Medical University in Poznań, Poland
Adres autora: Robert Juszkat, Department of Radiology, Karol Marcinkowski University of Medical Science, 
Długa 1/2 str., 61-848 Poznań, e-mail: robertju@wp.pl
 Summary
	 Background:  Angioplasty	 of	 occluded	 iliac	 arteries	 connected	with	 stent	 implantation	demonstrated	 the	high	
technical	efficacy	and	good	clinical	effect	of	the	stent.	The	patency	of	iliac	vessel	stents	12	months	
after	 their	 implantation	 ranged	between	86	 and	99%,	depending	 on	 the	 author	 cited.	The	 aim	of	
the	study	was	to	determine	the	safety	and	clinical	efficacy	of	iliac	artery	angioplasty	following	the	
implantation	of	the	Polish	stent	Neptun,	manufactured	by	Balton.
 Material/Methods:  The	study	group	comprised	56	patients	aged	between	39	and	83	years	diagnosed	with	stenosis	or	
iliac	artery	occlusion,	subjected	to	 implantation	of	75	stents.	The	patients	were	directed	towards	
intravascular	 procedures	 on	 the	 basis	 of	 their	medical	 history	 as	well	 as	 clinical	 and	 imaging	
examinations,	 including	Doppler	ultrasound	and	DSA	angiography.	Clinical	 symptoms	were	based	
on	 Fontaine's	 classification,	 evaluated	 before	 the	 procedure	 and	 three	 days	 after.	 Considering	
the	 similar	 time	 intervals,	 the	 ankle-brachial	 index	 (ABI)	was	 evaluated.	 Distant	 results	were	
determined	on	the	basis	of	clinical	examinations	in	addition	to	the	ABI	estimation	performed	during	
the	 follow-up	visit	 12	months	 after	 the	 procedure.	Thirty-seven	patients	 required	 single	 stents,	
while	 in	9	 subjects	both	 iliac	arteries	were	 subjected	 to	 stenting,	 including	 the	abdominal	 aortic	
bifurcation.	 In	 six	 patients,	 stents	were	 implanted	 to	 both	 iliac	 arteries,	 the	 aortic	 bifurcation	
excluded.	Four	patients	were	subjected	to	the	implantation	of	two	stents,	involving	one	of	the	iliac	
arteries.		
	 Results:  In	 all	 patients	 a	 positive	 technical	 and	 clinical	 effect	was	 obtained.	 Improvement	 according	 to	
Fontaine’s	classification	was	observed	in	the	whole	study	group	of	patients	(evaluation	undertaken	
three	days	after	the	procedure).	The	mean	ankle-brachial	index	on	admission	was	0.62±0.17.	After	
angioplasty,	this	index	significantly	increased	(p<0.01)	to	0.87±0.19.	After	the	one-year	observation	
period	the	AB	index	decreased	to	0.82±0.18	(p=NS).	Ultrasonographic	control	comprised	49	patients	
with	65	 implanted	 stents.	Complete	vessel	patency	was	confirmed	 in	60	 (92.3%)	12	months	after	
stent	implantation.
	 Conclusions:  Based	on	this	evaluation,	Neptun	stents	are	safe,	their	technical	and	clinical	efficacy	amounting	to	
100%	during	 the	perioperative	period.	The	 stents	 assure	 good	visualization	during	 implantation.	
Their	patency	after	the	one-year	observation	period	proved	to	be	high,	being	comparable	to	other	
previously	used	stents.	Further	investigations	are	required,	involving	a	longer	follow-up	period.
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Background
Percutaneous	 iliac	 artery	 angioplasty	with	 stent	 implan-
tation	 is	 an	 effective,	minimally	 invasive	 and	 alternative	
method	of	 theapy,	 in	comparison	 to	classical	 surgical	pro-
cedures	applied	 in	the	treatment	of	aortic	and	 iliac	artery	
occlusion,	due	to	atherosclerosis	[1].	Especially	good	intra-
vascular	treatment	results	were	obtained	in	case	of	isolated	
iliac	artery,	short	segment	atheromatous	lesions	[2].	
For	more	 than	20	years	 the	 implantation	of	metallic	 stents	
has	 been	 considered	 as	 a	 supplemental	method	 of	 therapy,	
following	 unsatisfactory	 percutaneous	 angioplasty	 [3–5].	
Other	indications	for	stent	implantation	are	as	follows:	exten-
sive	dissection	of	the	arterial	wall	leading	towards	occlusion,	
symptomatic	 iliac	 artery	 ulceration,	 as	 well	 as	 restenosis	
after	previous	PCI	(percutaneous	intervention)	[6,	7].
Stent	 implantation	 is	undertaken	 in	 case	 of	 atheromatous	
arterial	 occlusion	or	 complex	 lesions,	 such	as	multi-layer,	
long-segmental,	eccentric	and	highly	calcified	lesions	[6,	8].	
Primary	stent	implantation	in	case	of	iliac	artery	occlusion	
is	also	connected	with	fewer	complications,	in	comparison	
to	PCI	without	stent	implantation	[7].	
Together	with	endovascular	 techniques	progress	and	 the	pro-
duction	of	new	generation	stents	the	efficacy	and	distant	intra-
vascular	iliac	artery	procedure	results	significantly	improved.	
Contemporary	 stents	 may	 be	 divided	 into	 two	 groups:	
mechanically	expandable	on	balloon	catheters	 (steel),	such	
as	 Palmaz-stents,	 and	 self-expandable	 stents	 (nickelic-
titanic	stents	–	SMART).
Until	 recently	 only	 imported	 stents	 were	 used,	 in	 spite	
of	 the	 increasing	 demands	 and	 indications	 towards	 their	
application.	
The	 aim	of	 this	 study	was	 to	 determine	 the	 safety,	 clini-
cal	 efficacy	 and	 distant	 treatment	 results	 following	 iliac	
artery	stenting	with	the	use	of	the	first	Polish	stent-Neptun	
mounted	on	the	balloon	catheter.
Material and methods
During	 the	 period	 between	 october	 2002	 and	 november	
2004,	56	patients	(67	extremities)	with	iliac	artery	stenosis	
or	 occlusion	 underwent	 treatment	 (implantation	 of	 75	
stents)	at	the	Department	of	General	and	Vascular	Surgery,	
as	 well	 as	 Vascular	 Laboratory	 of	 the	 Department	 of	
Radiology,	Medical	 Academy	 Poznan.	 Patient	 age	 ranged	
between	39	and	83	years	(mean	age	–	61.2	years),	including	
37	male	and	19	female	subjects.	
Qualification	of	patients	towards	 intravascular	procedures	
was	based	on	the	medical	history,	clinical	examination	and	
imaging	methods	(USG	–	doppler	and	DSA	angiography).
Clinical	 symptoms	were	evaluated	according	 to	Fontaine’s	
classification,	prior	to	the	procedure	and	three	days	there-
after.	The	AB	index	was	also	determined	at	the	same	time.	
In	order	to	determine	distant	results	after	12	months,	clini-
cal	and	ABI	evaluation	were	undertaken	during	the	control	
visit.	Tables	1	and	2	demonstrated	the	demographic	data	of	
the	investigated	group.	
Ultrasound	 doppler	 examinations	 were	 performed	 using	
Elegra	 equipment,	 manufactured	 by	 Siemens	 with	 two	
changeable	 frequency	probes:	2.5	–	4.5	MHz	and	5.5	–	9.5	
MHz.	Each	 time	 the	 examination	 comprised	 the	 spectrum	
and	 flow	 velocity	measurements	 through	 the	 abdominal	
aorta	and	iliac	arteries.	The	above-mentioned	were	always	
performed	before	DSA	angiogarphy,	 12	months	 after	 stent	
implantation,	as	well	as	 in	case	of	clinical	 symptoms	sug-
gestive	of	recurrent	occlusion.	
DSA	angiography	of	 the	 lower	 extremity	vessels	was	per-
formed	 by	means	 of	 Seldinger’s	 method	with	 the	 place-
ment	of	the	diagnostic	catheter	in	the	distal	segment	of	the	
abdominal	aorta.	A	non-ionic	 contrast	medium	was	 intro-
duced	by	means	of	an	automatic	syringe	at	a	dose	of	20–30	
ml	(flow:	10–20	ml/s).
The	degree	of	arterial	stenosis	and	length	of	the	atheroma-
tous	lesion	were	estimated	during	DSA	angiography,	on	the	
basis	of	catheter	calibration.	
Iliac	artery	lesions	were	retrospectively	divided,	according	
to	the	TASC	classification	[6]:	group	A	–	24	patients,	group	
B	 –	 16	 patients,	 group	 C	 –	 11	 patients,	 and	 group	D	 –	 5	
patients.
Iliac	artery	angioplasty	with	stent	implantation	was	directly	
performed	 after	DSA	 angiography.	After	 arterial	 puncture	
by	means	of	Seldinger’s	method,	a	7F,	10	cm	long	introducer	Table 1.  Risk factors of patients with stenosis or iliac vessel occlusion 
(n=56).
Tabela 1.  Czynniki ryzyka chorych z przewężeniem lub niedrożnością 
naczyń biodrowych (n=56).
Smoking 44 (78.6%)
Hypertension 25 (44.6%)
Diabetes mellitus 5 (8.9%)
Hyperlipidemia 21 (37.5%) 
Coronary heart disease 12 (21.4%)
Kidney insufficiency 1 (1.8%)
Table 2.  Clinical symptoms of patients with stenosis or iliac vessel 
occlusion-according to Fontaine’s classification (n=56).
Tabela 2.  Objawy kliniczne chorych z przewężeniem lub niedrożnością 
naczyń biodrowych – klasyfikacja wg Fontaine’a (n=56).
Claudication > 200 m (IIa)  11
Claudication between 100 – 200 m (IIb)  26
Claudication < 100 m (IIb)  8
Rest pain (III)  4
Crural ulceration (IV)  7
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(Balton)	was	placed	into	the	common	femoral	artery	or	both	
common	 femoral	 arteries.	 In	 47	 cases,	 0.35J	 hydrophilic	
guides	(Terumo)	were	used,	while	in	24	cases,	0.32J	teflonic	
guides	(Balton).
In	all	cases	the	Polish-Neptun	stent	was	used,	produced	by	
Balton	(Balton,	Warsaw,	Poland),	mounted	on	balloon	cath-
eters.	 Balloon	 predilatation	was	 performed	 in	 case	 of	 44	
atheromatous	 lesions	 (58.6%),	while	 31	 (41.4%)	were	 sub-
jected	 to	 primary	 stenting.	Considering	 initial	 iliac	 artery	
dilatation,	 6–8mm	 in	 diameter	 and	 2–8cm	 long	 balloon	
catheters	were	used.	 In	11	 cases	 of	 iliac	 artery	 occlusion,	
intravascular	 subintimal	 patency	 restoration	by	means	 of	
Boli’s	method	was	undertaken	[9,	10]	(fig.	1).	The	diameter	
of	 implanted	 stents	 ranged	 between	 7–10	mm,	while	 the	
length	–	3–8	cm.
During	the	performed	procedures	we	subjectively	estimated	
the	visibility	of	the	stent,	according	to	the	following	scale:	
poor,	good,	very	good.	
All	patients	 received	5000	units	of	unfractionated	heparin	
during	premedication.	After	the	procedure	patients	received	
ticlopidine	at	a	dose	of	2x250	mg	for	a	period	of	3	months,	
and	aspirin	for	12	months	at	a	dose	of	150	mg,	once	daily.	
The	 technical	 evaluation	 of	 the	 angioplasty	 with	 stent	
implantation	was	based	on	 three	 elements:	 arteriographic	
stent	 localization,	 proper	 adjustment	 to	 the	vascular	wall	
(expansion),	 as	 well	 as	 presence	 of	 remaining	 stenoses	
(≤30%	and	>30%).	
Clinical	 success	 of	 the	 procedure	was	 obtained	 in	 case	 of	
reduction	 of	 symptoms,	 according	 to	 Fontaine’s	 classifi-
cation,	 considering	 patients	 primarily	 qualified	 towards	
the	 2	and	 3	 group	 (one	 grade),	 and	 those	 in	 group	4	 (two	
grades).	 In	 order	 to	 objectivize	 the	 clinical	 effect	we	 also	
determined	 the	AB	 index,	 before	 and	 after	 the	performed	
procedure.	
In	case	of	clinical	symptoms	recurrence	and	AB	index	dete-
rioration	during	the	observation	period,	patients	were	sub-
jected	to	control	angiography.	
Statistical	analysis	was	performed	by	means	of	the	t-Student	
test,	 considering	 related	 variables,	 as	well	 as	 the	 chi2	 test	
using	the	STATISTICA	program	(Windows	5.1	(PL),	manufac-
tured	by	 StatSoft,	 Inc.).	 p<0.05	was	 considered	 as	 statisti-
cally	significant.
Characteristics	of	the	Polish	stent-Neptun	
The	 peripheral	 stent	 (Neptun)	 is	 cut	 from	medical	 steel	
during	 its	 production	by	means	 of	 a	 laser	 (316	LVM).	The	
above-mentioned	is	a	non-ferrous	magnetic	material,	thus,	
patients	with	Neptun	stents	may	be	subject	to	MRI	exami-
nations.	The	balloon	mounted	stent	is	pointed	out	by	golden	
markers,	visible	during	radiological	examinations.	
Ready-made	stents	are	mounted	on	80	and	110	cm	balloon	
catheters.	 Their	 diameter	 ranged	 between	 4	 and	 10	mm,	
and	 length	 between	 16–100	 mm.	 The	 pressure	 applied	
	during	 expansion	 amounted	 to	 6	 atmospheres,	 maxi-
mum	 –	10	 atm.	 6–8F	 introducers	 are	 used,	 depending	 on	
the	 diameter	 of	 the	 stent.	 The	 manufacturer	 mentioned	
the	 admissible	 shortening	 of	 the	 stent	 during	 expansion,	
<5%	its	initial	length,	as	well	as	its	diameter	of	<2%	after	
implantation*.
Results
In	 case	 of	 all	 our	 patients	 (100%)	 technical	 success	was	
obtained	after	stent	implantation.	In	31	of	44	stent	implan-
tation	procedures,	considering	balloon	predilatation,	imme-
diate	good	effects	were	obtained	after	angioplasty	alone.	We	
noted	internal	layer	separation	considering	13	of	44	proce-
dures	with	predilatation	 (29.5%)	 after	 balloon	 angioplasty	
(fig.	2).	None	of	the	procedures	posed	technical	difficulties,	
considering	 the	 insertion	 of	 the	 stent	 through	 the	 athero-
matous	lesion.	
In	 3	 of	 31	 primarily	 stented	 lesions	 complications	 were	
noted	 during	 the	 passage	 of	 the	 catheter	 through	 the	
occluded	iliac	artery.	In	one	case	we	observed	the	displace-
ment	of	the	stent	from	the	balloon	catheter.	These	patients	
were	 subjected	 to	 balloon	 angioplasty	 followed	 by	 iliac	
artery	 stenting.	 In	 the	 remaining	 28	 cases	 the	 procedure	
posed	no	difficulties.	
During	expansion	of	Neptun	stents	we	observed	the	filling	
of	the	balloon	in	its	proximal	part	followed	by	expansion	of	
the	distal	part.	Stent	expansion	at	the	proximal	and	distal	
Figure 1.  DSA angiography. Impatency of the right iliac artery system. 
Subintimal guide introduced into the abdominal aorta.
Rycina 1.  Badanie DSA i.a. Niedrożność układu tętnic biodrowych 
po stronie prawej. Prowadnik subintimalnie przeprowadzony 
do aorty brzusznej.
*	Technical	data	considering	“Neptun”	stents	were	based	on	the	manufacturer’s	leaflets	(Balton).
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ends,	nearly	 simultaneously,	 enabled	 to	optimally	position	
the	stent	reducing	the	possibility	of	 their	displacement,	 in	
relationship	to	atheromatous	lesions.	
Thirty-seven	patients	were	subjected	to	single	stent	implan-
tations,	while	nine	required	stents	to	both	iliac	arteries	and	
the	 abdominal	 aortic	 bifurcation	 (kissing stents)	 (fig.	 3).	
In	six	cases	stents	were	introduced	bilaterally,	the	abdomi-
nal	aortic	bifurcation	excluded.	Four	patients	required	two	
stents	 on	one	 side.	A	positive	 technical	 and	 clinical	 effect	
was	 observed	 in	 all	 patients.	 Incomplete	 stent	 expan-
sion	and	 translocation,	 as	well	 as	vessel	 perforation	were	
absent.	 We	 observed	 minimal	 shortening	 of	 the	 stents	
	during	 the	expansion	procedure,	being	 in	accordance	with	
the	producer’s	instructions.	
During	 angioplasty	 procedures	we	 subjectively	 evaluated	
the	 visibility	 of	 the	 stents,	which	 turned	 out	 to	 be	 very	
good	in	90%	of	cases,	and	good	in	the	remaining.	
After	 angioplasty	 only	 two	 local	 complications	 were	
observed-hematomas,	without	 the	need	 for	 surgical	 inter-
vention.	Directly	after	the	procedures	stent	thrombosis	was	
not	observed.	Peripheral	emboli	were	also	absent.	
The	mean	AB	 index	value	before	 the	procedure	amount-
ed	 to	 0.62±0.17.	 Three	 days	 after	 the	 procedure,	 the	
above-mentioned	 increased	 to	 0.87±0.19,	 being	 sta-
tistically	 significant	 (p<0.01).	 After	 12	 months	 the	
AB	 index	 decreased	 to	 0.82±0.18,	 being	 statistically	
insignificant.	
Three	days	after	stent	implantation,	according	to	Fontaine’s	
classification,	patients	were	qualified	 to	a	 lower	grade,	 in	
comparison	to	pre-procedure	evaluations.	
Two	 (4.1%	 subjected	 to	 stent	 implantation)	 patients	were	
admitted	 to	 the	Department	during	 the	 initial	 six	months	
after	the	procedure,	due	to	 iliac	artery	thrombosis.	 In	one	
case	the	patient	presented	with	one	stent,	while	the	latter	
female	patient	was	treated	by	means	of	the	“kissing-stent”	
method.	Both	patients	were	subjected	to	successful	“cross-
over”	fibrinolytic	treatment.	Streptokinase	was	used	as	the	
fibrinolytic	 agent,	 administered	 for	 48	hours	 at	 a	 dose	 of	
20000	U/hour.	The	efficacy	of	treatment	was	evaluated	on	
the	basis	 of	 clinical	 symptoms,	 angiographic	 examination,	
fibrinogen	 level	 reduction	 and	 prolonged	 thrombin	 time.	
After	 streptokinase,	 patients	 received	 intravenous	heparin	
for	a	period	of	 five	days,	 followed	by	oral	anticoagulation	
for	 a	 period	 of	 six	months.	Complications	 connected	with	
streptokinase	 and	 oral	 anticoagulant	 administration	were	
absent.	The	clinical	and	radiological	effects	were	good.	
Forty-nine	patients	with	65	implanted	stents	were	subject-
ed	 to	 yearly	ultrasound	 examinations.	 Seven	patients	 did	
not	show	up	 for	control	visits.	Complete	vascular	patency	
was	observed	in	case	of	60	(92.3%)	stents,	12	months	after	
their	implantation.	
Discussion
The	use	of	 stents	 is	an	acknowledged	and	effective	 thera-
peutical	method,	 considering	patients	with	 lower	 extrem-
ity	atheromatous	lesions.	Stenting	is	especially	beneficial	in	
case	of	 the	 incomplete	hemodynamic	and	clinical	effect	of	
angioplasty	 [1].	 In	 such	cases	 stent	 implantation	might	be	
a	planned	procedure	and	dose	not	have	 to	be	preceded	by	
predilatation	angioplasty	[11].	The	latter	is	only	performed	
in	 case	of	 ineffective	angioplasty	with	 significant	 residual	
stenosis	[12].	
Advocates	of	primary	stenting	ascertained	that	the	above-
mentioned	 reduces	 the	percentage	 of	 peripheral	 embolism	
Figure 2.  Subintimal iliac artery angioplasty on the right side. Visibly 
detached internal layer flap.
Rycina 2.  Subintimalna angioplastyka tętnic biodrowych po stronie 
prawej. Widoczny odwarstwiony fałd błony wewnętrznej.
Figure 3.  Neptun stents implanted into both common iliac arteries, 
the “kissing-stents” type of angioplasty.
Rycina 3.  Stenty Neptun wszczepione do obu tętnic biodrowych 
wspólnych. Angioplastyka typu „kissing-stents”.
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and	arterial	wall	separations,	possibly	connected	with	bet-
ter	distant	results	considering	stenting	[11,	13].	It	is	worth	
pointing	 out	 that	 in	 the	 subgroup	of	 patients	 subjected	 to	
stent	 implantations	preceded	by	balloon	predilatation	 the	
immediate	 good	 effect	 after	 angioplasty	was	 observed	 in	
70.5%	of	 cases	 (31	 of	 44	procedures).	 In	 case	 of	 13	proce-
dures	 (29.5%	of	 the	predilatation	 group)	 following	balloon	
angioplasty	we	observed	internal	layer	separation.	
Prospective	investigations	demonstrated	that	the	percentage	
of	complications,	distant	vessel	patency,	as	well	as	reinter-
vention	were	 similar,	 both	 in	 case	 of	 angioplasty	 and	pri-
mary	stenting	[12].	Based	on	our	observations	and	literature	
data	 stent	 implantation	 should	be	 the	method	of	 choice	 in	
case	of	the	incomplete	effect	of	angioplasty	[12,	14],	as	well	
as	during	 the	course	of	arterial	dissection	 [14].	The	above-
mentioned	 complication	 was	 observed	 in	 case	 of	 30%	 of	
patients.	Thus,	primary	stenting	seems	fully	justified.	
Polish	Neptun	stents	enabled	to	maintain	patency	in	92.3%	
of	patients,	after	a	one	year	observation	period.	The	result,	
being	 comparable	 to	 literature	 data,	where	 patency	 after	
one	year	ranged	between	91–94%	[15–16].
Expandable	 stents	 mounted	 on	 balloon	 catheters	 differ	
from	 self-expandable	 steel	 or	 nickel	 stents	 not	 only	 by	
means	of	the	implantation	technique.	The	presence	of	the	
stent	 on	 the	balloon	 catheter	 enables	 its	 precise	 localiza-
tion,	 considering	 any	 segment	 of	 the	 iliac	 artery,	which	
reduces	 the	 risk	 of	 uncontrolled	 stent	 slipping	 during	
expansion.	The	use	 of	 expandable	 balloon	 stents	 enables	
better	 control	 of	 their	 localization,	 in	 comparison	 to	 the	
use	of	self-expandable	nitinol	stents.	The	above-mentioned	
technique	 is	 also	 easier	 to	 perform	 [14,	 17].	 Considering	
the	 analysed	 material	 immediate	 technical	 success	 was	
obtained	in	100%	of	cases.	
The	 evaluated	 first	 expandable	 Polish	 stent	 (Neptun),	
manufactured	by	Balton	was	well	 visualized	during	x-ray	
examinations,	compared	to	other	foreign	company	stents.	
There	 are	 different	methods	 determining	 the	 efficacy	 of	
angioplasty	or	iliac	artery	stenting:	clinical	evaluation	(sub-
jective	 symptoms,	 according	 to	 Fontaine’s	 classification,	
and	ABI	analysis),	as	well	as	radiological	assessment	(ultra-
sonography	 and	 angiography).	 Many	 authors	 considered	
treatment	 as	 effective,	when	 residual	 stenosis	 amounted	
to	<5–30%	 during	 angiography	 [11,17],	 and	 the	 pre-	 and	
post-stenosis	 pressure	 gradient	<10	mmHg	 [17].	 German	
investigators	analysed	ABI	values,	considering	the	objective	
and	non-invasive	 evaluation	 of	 the	 efficacy	 of	 the	 proce-
dure	[11,	14,	17].	We	determined	the	efficacy	of	the	proce-
dure	on	the	basis	of	the	clinical	evaluation	(pulse	palpation,	
subjective	evaluation	of	symptoms,	according	to	Fontaine’s	
classification,	and	ABI	analysis),	and	complete	radiological	
assessment.	
Immediate	 technical	 efficacy	 was	 obtained	 in	 100%	 of	
cases,	and	the	percentage	of	patent	stents	after	a	one-year	
follow-up	period	amounted	to	92.3%.	The	above-mentioned	
values	are	similar	to	those	obtained	by	other	authors,	per-
centages	ranging	between	88–100%	[1,13,14,18–19].	Clinical	
condition	 improvement,	 based	 on	 subjective	 symptoms	
(Fontaine’s	 scale	 and	 the	 ankle-brachial	 index	 (ABI)	was	
similar	to	literature	data	results	[11,13–14].	This	objectively	
confirms	that	Neptun	stent	properties	are	similar	to	those	
of	other	stents,	treatment	results	being	comparable	to	those	
of	other	authors.	
The	 efficacy	 of	 angioplasty	 and	 iliac	 artery	 stenting	
depends	 on	 the	 length	 of	 the	 stenosed	 or	 occluded	 ves-
sel	 segment	 [2,13,19].	 Colapinto	 and	 co-authors	 demon-
strated	 that	 the	procedure	was	 effective	 in	92%	of	 cases,	
	considering	the	occluded	 length	of	the	vessel	<5	cm.	The	
above-mentioned	 amounted	 to	 70%	 in	 case	 of	 occlusion	
exceeding	>5	cm	[2].	The	patency	of	stents	after	long-last-
ing	observations	was	as	follows:	91–94%	of	patients	after	
6	months	[14,20],	89–95%	after	one	year	[1,20],	84.2–98.2%	
after	two	years	[1,18–19],	and	82%	after	four	years	[1].	Our	
observations	seem	to	confirm	the	above-mentioned,	since	
considering	 7.7%	 of	 patients	with	 occluded	 iliac	 arteries	
on	the	side	of	the	implanted	stent,	all	presented	with	ste-
nosis	exceeding	5cm.	
No	significant	complications	were	noted	after	stent	implan-
tation,	 as	 presented	 in	 literature	 data:	 vascular	 rupture,	
translocation	or	early	stent	thrombosis,	as	well	as	peripher-
al	embolism.	Two	patients	were	diagnosed	with	hematomas	
at	 the	 site	 of	 the	 femoral	 artery	puncture,	which	did	not	
require	surgical	 intervention.	The	percentage	of	complica-
tions	following	iliac	artery	stent	implantations	amounted	to	
6.8%	[1].	Particular	complications,	based	on	literature	data	
were	 observed	as	 follows:	peripheral	 embolism	–	0–26.1%	
	of	cases	(13,17],	vessel	dissection	after	percutaneous	trans-
luminal	 angioplasty	 –	 10.7%	of	 cases	 [18],	 early	 thrombo-
sis	–	17.4%	of	cases	[13],	stent	translocation	–	7.1%	of	cases	
[18],	and	vessel	perforation	–	3.6%	of	cases	[18].	In	case	of	
our	 patients	 only	 vascular	 dissection	was	 noted	 (signifi-
cantly	higher	percentage).	
In	order	 to	decrease	 the	 risk	of	peripheral	 embolism	after	
intravascular	 treatment	 (angioplasty	 and	 eventual	 stent	
implantation),	 the	 above-mentioned	 should	 be	 performed	
in	case	of	patients	with	recent	(<3	months)	vascular	occlu-
sions.	 According	 too	 other	 investigations	 such	 a	 short	
	period	from	vessel	closure	is	considered	as	an	exclusion	cri-
terion	of	angioplasty	and	stent	implantation	[17].	
Some	 authors	 mentioned	 that	 most	 iliac	 artery	 stenting	
complications	might	be	 treated	by	means	 of	 intravascular	
procedures.	One	 should	not	 forget	 about	 the	high	 conver-
sion	rate,	amounting	to	12.5%	of	cases	[18].	In	the	presented	
study	conversion	was	absent.	
Considering	 two	 cases	we	 observed	 stent	 thrombosis,	 six	
months	 after	 the	 procedure.	 The	 following	 factors	might	
be	 responsible	 for	 distant	 stent	 occlusion:	 residual	 steno-
sis,	restenosis,	as	well	as	stent	abnormalities	[13].	Clinically	
significant	 restenosis	 (50–75%)	was	 observed	 in	9–9.5%	of	
cases	[11,14,17].	It	seems	that	delayed	stent	closure,	due	to	
restenosis	or	breakage	might	be	connected	with	procedures	
performed	on	long	vascular	stenoses/occlusions	[13].	In	case	
of	late	intravascular	stent	impatency,	angioplasty	seems	to	
be	the	recommended	method	of	choice	[11,	17].	Considering	
both	described	 cases	 of	 late	 impatency,	 fibrinolytic	 treat-
ment	was	initiated.	
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Conclusions
Analysis	of	the	presented	material	enabled	the	following:
1.		Iliac	 artery	 stenting	 with	 the	 use	 of	 the	 first	 Polish-
Neptun	stent	is	a	safe	and	effective	method.
2.		Results	 following	 stent	 implantation	 after	 a	 period	 of	
12	months	 are	 similar	 to	 those	 observed	 in	 literature	
data.	
3.		Further	 investigations	 comprising	 a	 larger	 number	 of	
patients	and	longer	observation	period	are	required.
